Checkmate-040: Nivolumab (NIVO) in patients (pts) with advanced hepatocellular carcinoma (aHCC) and Child-Pugh B (CPB) status.-MedSci.cn

Checkmate-040: Nivolumab (NIVO) in patients (pts) with advanced hepatocellular carcinoma (aHCC) and Child-Pugh B (CPB) status.

Kudo, M; Matilla, A; Santoro, A; Melero, I; Gracian, AC; Acosta-Rivera, M; Choo, SP; El-Khoueiry, AB; Kuromatsu, R; El-Rayes, BF; Numata, K; Itoh, Y; Di Costanzo, F; Crysler, OV; Reig, M; Shen, Y; Neely, J; Dela Cruz, CM; Baccan, C; Sangro, B

JOURNAL OF CLINICAL ONCOLOGY, 2019; 37 (4):

科室
- - 订阅+
  - 更多科室
工具
服务